Relmada Therapeutics, Inc. (RLMD) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Total Current Assets | 235.34M | 93.98M | 14.85M | 21.09M | 27.66M | 45.8M | 55.7M | 70.97M | 84.37M | 97.51M | 109.1M | 122M | 135.53M | 152.87M | 187.11M | 215.74M | 225.78M | 223.3M | 90.89M | 110.7M |
| Cash & Short-Term Investments | 233.96M | 93.01M | 13.89M | 20.62M | 27.06M | 44.91M | 54.12M | 70.44M | 83.61M | 96.32M | 106.27M | 118.53M | 132.44M | 148.32M | 184.15M | 211.96M | 220.65M | 211.91M | 88.09M | 109.07M |
| Cash Only | 9.78M | 3.5M | 1.38M | 1.35M | 1.15M | 3.86M | 1.48M | 2.09M | 1.34M | 4.09M | 6.7M | 14.47M | 28.89M | 5.4M | 42.52M | 37.26M | 44.93M | 44.44M | 11.45M | 4.67M |
| Short-Term Investments | 224.19M | 89.51M | 12.5M | 19.27M | 25.91M | 41.05M | 52.63M | 68.35M | 82.28M | 92.23M | 99.57M | 104.06M | 103.55M | 142.93M | 141.63M | 174.69M | 175.72M | 167.47M | 76.64M | 104.4M |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 512.43K | 0 | 42.23K | 65.45K | 86.38K | 0 | 82.84K |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 1.38M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 37 | 0 | 0 | 0 | 0 | 256.24K | 0 | 35 | 84.59K | 76.88K |
| Total Non-Current Assets | 19.5K | 19.5K | 21.97K | 21.98K | 21.98K | 21.98K | 21.98K | 53.63K | 43.13K | 43.13K | 47.72K | 34.59K | 34.88K | 34.88K | 16.09K | 35.24K | 28.29K | 28.29K | 47.27K | 69.09K |
| Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 19.5K | 19.5K | 21.97K | 21.98K | 21.98K | 21.98K | 21.98K | 53.63K | 43.13K | 43.13K | 47.72K | 34.59K | 34.88K | 34.88K | 16.09K | 35.24K | 28.29K | 28.29K | 47.27K | 69.09K |
| Total Assets | 235.36M | 94M | 14.88M | 21.12M | 27.68M | 45.82M | 55.72M | 71.03M | 84.41M | 97.55M | 109.15M | 122.04M | 135.57M | 152.91M | 187.12M | 215.77M | 225.81M | 223.33M | 90.93M | 110.77M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 750.32% | 105.17% | -73.3% | -70.27% | -67.21% | -53.03% | -48.95% | -41.8% | -37.74% | -36.2% | -41.67% | -43.44% | -39.96% | -31.53% | 105.78% | 94.79% | 117.4% | 88.96% | -27.6% | -17.68% |
| Total Current Liabilities | 12.89M | 6.43M | 5.19M | 5.13M | 5.23M | 10.29M | 8.09M | 9.54M | 12.36M | 12.19M | 8.42M | 10.7M | 10.1M | 12.47M | 20.78M | 18.92M | 15.41M | 15.06M | 18.25M | 13.92M |
| Accounts Payable | 5.73M | 1.57M | 1.45M | 1.36M | 1.27M | 4.13M | 2.35M | 4.17M | 5.19M | 3.51M | 2.86M | 4.85M | 4.42M | 5.26M | 10.43M | 7.54M | 10.67M | 11.19M | 12.71M | 10.46M |
| Days Payables Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 7.16M | 4.86M | 1.82M | 2.23M | 1.02M | 1.15M | 5.74M | 1.02M | 0 | 5.68M | 1.46M | 0 | 0 | 1.02M | 8.52M | 1.35M | 0 | 1.64M | 0 | 1.06M |
| Current Ratio | 18.26x | 14.62x | 2.86x | 4.11x | 5.29x | 4.45x | 6.89x | 7.44x | 6.82x | 8.00x | 12.95x | 11.40x | 13.42x | 12.26x | 9.01x | 11.40x | 14.65x | 14.83x | 4.98x | 7.95x |
| Quick Ratio | 18.26x | 14.62x | 2.86x | 4.11x | 5.29x | 4.45x | 6.89x | 7.44x | 6.82x | 8.00x | 12.95x | 11.40x | 13.42x | 12.26x | 9.01x | 11.40x | 14.65x | 14.83x | 4.98x | 7.95x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 3.74M | 1.06M | 221.11K | 32.12K | 7.5K | 4.47K | 12.56K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 3.74M | 1.06M | 221.11K | 32.12K | 7.5K | 4.47K | 12.56K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 16.63M | 7.49M | 5.41M | 5.17M | 5.24M | 10.3M | 8.1M | 9.54M | 12.36M | 12.19M | 8.42M | 10.7M | 10.1M | 12.47M | 20.78M | 18.92M | 15.41M | 15.06M | 18.25M | 13.92M |
| Total Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Debt | -9.78M | -3.5M | -1.38M | -1.35M | -1.15M | -3.86M | -1.48M | -2.09M | -1.34M | -4.09M | -6.7M | -14.47M | -28.89M | -5.4M | -42.52M | -37.26M | -44.93M | -44.44M | -11.45M | -4.67M |
| Debt / Equity | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 218.73M | 86.51M | 9.47M | 15.95M | 22.44M | 35.52M | 47.63M | 61.49M | 72.05M | 85.36M | 100.73M | 111.34M | 125.47M | 140.44M | 166.34M | 196.85M | 210.4M | 208.26M | 72.69M | 96.85M |
| Equity Growth % | 874.72% | 143.55% | -80.12% | -74.06% | -68.85% | -58.38% | -52.72% | -44.77% | -42.58% | -39.22% | -39.45% | -43.44% | -40.37% | -32.57% | 128.85% | 103.25% | 130.83% | 97.25% | -40.52% | -26.76% |
| Book Value per Share | 2.53 | 1.27 | 0.29 | 0.48 | 0.74 | 1.18 | 1.58 | 2.04 | 2.39 | 2.84 | 3.35 | 3.70 | 4.17 | 4.67 | 5.53 | 6.58 | 7.41 | 10.91 | 4.16 | 5.68 |
| Total Shareholders' Equity | 218.73M | 86.51M | 9.47M | 15.95M | 22.44M | 35.52M | 47.63M | 61.49M | 72.05M | 85.36M | 100.73M | 111.34M | 125.47M | 140.44M | 166.34M | 196.85M | 210.4M | 208.26M | 72.69M | 96.85M |
| Common Stock | 104.89K | 73.33K | 33.19K | 33.19K | 33.19K | 30.17K | 30.17K | 30.17K | 30.17K | 30.1K | 30.1K | 30.1K | 30.1K | 30.1K | 28.64K | 30.02K | 29.4K | 27.74K | 17.5K | 17.47K |
| Retained Earnings | -717.32M | -698.27M | -678.4M | -668.31M | -658.44M | -640.88M | -622.22M | -600.5M | -582.73M | -560.9M | -535.74M | -513.74M | -488.43M | -462.11M | -424.17M | -384.75M | -344.81M | -305.07M | -270.69M | -228.08M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |